This document discusses several potential mechanisms of insulin resistance including increased levels and activity of PTP-1B, impaired phosphorylation of the insulin receptor and IRS-1, reduced PI-3 kinase activity, and attenuated insulin signaling. This leads to reduced phosphorylation of ApoB or its chaperone, enhanced stability and accelerated assembly of ApoB, and overproduction of VLDL. The document also discusses the contribution of intestinal lipoproteins to metabolic dyslipidemia in insulin resistance, and a hypothesis that fasting and postprandial hyperlipidemia in insulin resistant states may be attributable in part to intestinal oversecretion of apoB-48 containing lipoproteins.